About us

Lawarence press is an information solution company’s endeavour to bring information among research professionals of the health, science and technology sectors.
We publish contents with the mission to provide information which is universally accessible. We provide easily accessible and elegant online publishing solutions.
Our mission is to empower research work providing web-based digital publishing platform solutions of an international standard. .
Our company vision is to provide the highest standard in an online publishing platform.
We value innovation, originality & quality.

Chemo-radiation in Small Cell Neuroendocrine Carcinoma Oesophagus: A Case Report

Rakesh Kumar Gupta, Amitabh Kumar Upadhyay, Nidhi Gupta, Vijay Jagad, Munish Mahajan, Pankaj Goyal

Abstract


Primary small cell neuroendocrine carcinoma oesophagus is a very rare tumour, treated with radiotherapy and chemotherapy. A 55-year-old female presented with complaint of dysphagia, investigated and diagnosed as small cell neuroendocrine carcinoma oesophagus. She was treated with radiotherapy 45Gy/25#/5 weeks +10Gy/5#/1 week (boost) by 3D CRT technique and six cycles of chemotherapy with Inj.Etoposide 100 mg/m2 D1-D3 and Inj.Cisplatin 75 mg/m2 D1, Q3 weekly. On follow-up investigations, there was no evidence of local or metastatic disease. She is still disease free after 17 months of diagnosis.349

Keywords


Chemo-radiation,Carcinoma

Full Text:

References


Mckeown F. Oat-cell carcinoma of the oesophagus. J Pathol Bacteriol. 1952;64:889–891.

Casas F, Ferrer F, Farrús B, Casals J, Biete A. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer. 1997;80:1366–1372.

Hudson E, Powell J, Mukherjee S, Crosby TD, Brewster AE,

Maughan TS, et al. Small cell esophageal carcinoma: an institutional experience and review of the literature. Br J Cancer.2007;96:708–711.

Nichols GL, Kelsen DP. Small cell carcinoma of the esophagus.The Memorial Hospital experience 1970 to 1987. Cancer.1989;64:1531–1533.

Huncharek M, Muscat J. Small cell carcinoma of the esophagus. The Massachusetts General Hospital experience, 1978 to 1993.Chest. 1995;107:179–181.

Nishimaki T, Suzuki T, Nakagawa S, Watanabe K, Aizawa K,Hatakeyama K. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma. J Surg Oncol.1997;64:130–134.

Fer MF, Levenson RM, Cohen MH, et al. Extra pulmonary small cell carcinoma. In: Greco FA, Oldham RK, Bunn PA, editors. Small cell lung cancer. New York: Grune & Stratton; 1981. p. 301–325.

Yang L, Sun X, Zou Y, Meng X. Small cell type neuroendocrine carcinoma colliding with squamous cell carcinoma at esophagus.Int J Clin Exp Pathol. 2014;7:1792e5

Mitani M, Kuwabara Y, Shinoda N, Sato A, Fujii Y. Long-term survivors after the resection of limited esophageal small cell carcinoma. Dis Esophagus. 2000;13:259–261.

Medgyesy CD, Wolff RA, Putnam JB, Ajani JA. Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer.2000;88:262–267.

Pantvaidya GH, Pramesh CS, Deshpande MS, Jambhekar NA, Sharma S, Deshpande RK. Small cell carcinoma of the esophagus:The Tata Memorial Hospital Experience. Ann Thorac Surg.2002;74:1924–1927.

Nichols GL, Kelsen DP. Small cell carcinoma of the esophagus:the Memorial Hospital experience 1970–1987. Cancer.1989;64:1531–1533.

Yamashita H, Nakagawa K, Asari T, Murakami N, Igaki H,Okuma K, et al. Concurrent chemoradiation alone with curative intent for limited-disease small-cell esophageal cancer in nine Japanese patients. Dis Esophagus. 2009;22:113–118.

Atsumi K, Shioyama Y, Nomoto S, Ohga S, Toba T, Sasaki T, et al.Chemoradiation for small cell esophageal carcinoma: report of 11 cases from multi-institution experience. J Radiat Res. 2010;51:15–20.

Egashira A, Morita M, Kumagai R, Taguchi KI, Ueda M, Yamaguchi S, et al. Neuroendocrine carcinoma of the esophagus:Clinicopathological and immunohistochemical features of 14 cases. PLoS ONE. 2017;12:e0173501.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.